核内FOXM1驱动急性髓系白血病的化疗耐药。 - Suppr

Nuclear FOXM1 drives chemoresistance in AML.

作者信息

Khan I, Halasi M, Zia M F, Gann P, Gaitonde S, Mahmud N, Gartel A L

机构信息

Division of Hematology/Oncology, University of Illinois, Chicago, IL, USA.

Division of Gastroenterology/Hepatology, Department of Medicine,University of Illinois, Chicago, IL, USA.

出版信息

Leukemia. 2017 Jan;31(1):251-255. doi: 10.1038/leu.2016.270. Epub 2016 Oct 3.

DOI:10.1038/leu.2016.270

PMID:27694928

Abstract

摘要

相似文献

Nuclear FOXM1 drives chemoresistance in AML.

Leukemia. 2017 Jan;31(1):251-255. doi: 10.1038/leu.2016.270. Epub 2016 Oct 3.

FOXM1 contributes to treatment failure in acute myeloid leukemia.

JCI Insight. 2018 Aug 9;3(15). doi: 10.1172/jci.insight.121583.

Favorable outcomes of NPM1 AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance.

Blood Cancer J. 2023 Aug 22;13(1):128. doi: 10.1038/s41408-023-00898-4.

Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia.

Biochem Biophys Res Commun. 2014 Mar 28;446(1):280-5. doi: 10.1016/j.bbrc.2014.02.094. Epub 2014 Feb 28.

The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.

Carcinogenesis. 2010 Nov;31(11):2012-21. doi: 10.1093/carcin/bgq185. Epub 2010 Sep 7.

Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.

Histopathology. 2016 Jul;69(1):63-71. doi: 10.1111/his.12909. Epub 2016 Jan 11.

FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.

J Cell Biochem. 2017 Nov;118(11):3968-3975. doi: 10.1002/jcb.26052. Epub 2017 May 30.

Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.

Ann Surg Oncol. 2013 Mar;20(3):1035-43. doi: 10.1245/s10434-012-2680-0. Epub 2012 Oct 2.

FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.

Oncotarget. 2016 Sep 13;7(37):59245-59259. doi: 10.18632/oncotarget.11043.

DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.

Oncogene. 2017 Mar;36(10):1404-1416. doi: 10.1038/onc.2016.307. Epub 2016 Sep 5.

引用本文的文献

A stem cell differentiation model reveals two alternative fates in CBFA2T3::GLIS2-driven acute megakaryoblastic leukemia initiation.

Commun Biol. 2025 Aug 27;8(1):1289. doi: 10.1038/s42003-025-08730-4.

Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia.

Fundam Res. 2023 May 16;5(4):1781-1794. doi: 10.1016/j.fmre.2023.04.012. eCollection 2025 Jul.

Thiostrepton induces apoptotic cell death at the level of BCL-2/CED-9 in C. elegans.

Sci Rep. 2025 Jul 8;15(1):24415. doi: 10.1038/s41598-025-09446-5.

A novel FOXM1-BCL2A1 axis determines unfavorable response to venetoclax in AML.

J Biol Chem. 2025 Mar;301(3):108240. doi: 10.1016/j.jbc.2025.108240. Epub 2025 Jan 27.

Regulation of HOX gene expression in AML.

Blood Cancer J. 2024 Mar 7;14(1):42. doi: 10.1038/s41408-024-01004-y.

CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia.

Cancer Genomics Proteomics. 2024 Mar-Apr;21(2):118-136. doi: 10.21873/cgp.20434.

Favorable outcomes of NPM1 AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance.

Blood Cancer J. 2023 Aug 22;13(1):128. doi: 10.1038/s41408-023-00898-4.

The antagonistic duality of NPM1 mutations in AML.

Blood Adv. 2022 Jul 12;6(13):4028-4030. doi: 10.1182/bloodadvances.2022007420.

DRP1 contributes to head and neck cancer progression and induces glycolysis through modulated FOXM1/MMP12 axis.

Mol Oncol. 2022 Jul;16(13):2585-2606. doi: 10.1002/1878-0261.13212. Epub 2022 Apr 15.

Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.

BMC Cancer. 2021 Oct 28;21(1):1153. doi: 10.1186/s12885-021-08839-9.

本文引用的文献

A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS.

J Biol Chem. 2016 Jan 1;291(1):142-8. doi: 10.1074/jbc.M115.678227. Epub 2015 Nov 11.

The prognostic landscape of genes and infiltrating immune cells across human cancers.

Nat Med. 2015 Aug;21(8):938-945. doi: 10.1038/nm.3909. Epub 2015 Jul 20.

FOX(M1) news--it is cancer.

Mol Cancer Ther. 2013 Mar;12(3):245-54. doi: 10.1158/1535-7163.MCT-12-0712. Epub 2013 Feb 26.

Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.

J Clin Oncol. 2013 Mar 1;31(7):923-9. doi: 10.1200/JCO.2012.45.2177. Epub 2012 Nov 5.

Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells.

J Biol Chem. 2011 Dec 2;286(48):41425-41433. doi: 10.1074/jbc.M111.270843. Epub 2011 Oct 6.

The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.

Carcinogenesis. 2010 Nov;31(11):2012-21. doi: 10.1093/carcin/bgq185. Epub 2010 Sep 7.

Regulation of yeast forkhead transcription factors and FoxM1 by cyclin-dependent and polo-like kinases.

Cell Cycle. 2010 Aug 15;9(16):3233-42. doi: 10.4161/cc.9.16.12599. Epub 2010 Aug 2.

FoxM1 is a general target for proteasome inhibitors.

PLoS One. 2009 Aug 12;4(8):e6593. doi: 10.1371/journal.pone.0006593.

A novel mode of FoxM1 regulation: positive auto-regulatory loop.

Cell Cycle. 2009 Jun 15;8(12):1966-7. doi: 10.4161/cc.8.12.8708. Epub 2009 Jun 9.

Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia.

Blood. 2008 Feb 15;111(4):2364-73. doi: 10.1182/blood-2007-08-110171. Epub 2007 Dec 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Nuclear FOXM1 drives chemoresistance in AML.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献